SOURCE: Wake Pharma US, Inc.

Wake Pharma US, Inc.

September 15, 2009 01:00 ET

Wake Pharma US to Attend Society for Advance Wound Care Conference

ELK GROVE VILLAGE, IL--(Marketwire - September 15, 2009) - Wake Pharma US announced today that clinical evidence in the treatment of wounds using Wound-Be-Gone® will be presented at the fall Society for Advance Wound Care Conference. The SAWC is being held in Washington, DC from September 16-18, 2009. The clinical evidence and data will be presented through posters on display during the meeting.

Maggie Jankowski, COO of Wake Pharma US, Inc., commented: "Since the launch of Wound-Be-Gone® in June 2008, we have accumulated clinical experience from all types of wounds. Our product is very unique; and the only over-the-counter product available to treat chronic wounds. We have a lot of patients where the expensive treatments like Hyperbaric Oxygen Therapy, V.A.C. Therapy, and even skin grafts have failed. Our product Wound-Be-Gone®, has the ability to assist in rapid patient healing with minimal product cost." Jankowski was even kind enough share a letter that they received from one of the recent patients:

"I am so grateful to have had the opportunity to use the product, 'Wound-Be-Gone.' This product did for me in two (2) days what other methods took (3) three months, without any discomfort. When I saw my wounds un-bandaged in one (1) week, it brought tears to my eyes. I am a 50-year-old female with diabetes, who has lost my right leg (amputated), a little over 18 months ago. I really think with this product, I would still have my leg today. A very special 'thank you' for this wonderful gift of a brighter future!"

Tammy: Washington, D.C. 8/06/09

Jankowski went on to explain the bigger picture: "We want the product Wound-Be-Gone® to be recognized by the physicians, because they are the one who are seeing the patients on daily basis. Currently, over a billion dollars are spent each year developing effective wound care technology. With the advent of Wound-Be-Gone®, the overall cost of treating chronic wounds could be significantly reduced. Wound-Be-Gone® is putting wound care into the hands of people."

As an inexpensive yet very effective aid to healing, Wound-Be-Gone® is changing the way people treat chronic, non-healing wounds and as well acute wounds.

Wake Pharma US, Inc. encourages the adoption of cost-effective wound healing approaches for acute and chronic wounds management.

Wound-Be-Gone® is a novel product based on revolutionary technology in the healing of wounds. Based on a unique and patented principle, it is vastly different from current healing products on the market. It has a wide range of uses with a minimal side effect profile and minimal contraindications. It contains no antibiotics or material of biological origin.

About Wake Pharma US, Inc.:

Wake Pharma US, Inc. is an innovative and international company with its own manufacturing facility located in the European Union. Wake Pharma US, Inc. specializes in development, marketing and distribution of revolutionary and unique products to the health marketplace.

Visit our web site:

Contact Information